Form 4 for DFTX Definium Therapeutics, Inc.
Accepted 2024-12-05 00:00:00 ET · period of report 2024-12-05 · accession 0000950170-24-133724 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-12-05 | 2024-12-05 | DFTX | GRYSKA DAVID W | Dir | P - Purchase | $7.17 | +2,500 | 19.9K | +14% | +$17.9K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Shares | 2024-12-05 | P | A | 2,500 | $7.17 | 19,851 | D | — | — |